Class 4 Medicines Defect Information: Brillpharma Limited, Oxybutynin Hydrochloride Brillpharma 2.5 Mg/5 Ml Oral Solution, El(24)a/61
Recall Summary Oxybutynin hydrochloride Brillpharma 2.5 mg/5 ml Oral Solution in the United Kingdom contains an outdated patient information leaflet (dated July 2021) instead of the current version. This defect affects patients who received this medication, as they may not have access to the most recent safety and usage information. The manufacturer has notified the medicines regulator about this issue.
- Recalling firm
- Brillpharma Limited
- Reason
- L M Manufacturing Limited has informed the MHRA that the patient information leaflet (PIL) in the cartons for the batch listed for Oxybutynin hydrochloride Brillpharma 2.5 mg/5 ml Oral Solution include an out of date PIL, dated July 2021.
- Classification
- Class III
- Category
- drug recall
- Country
- United Kingdom
- Agency
- UK Medicines and Healthcare products Regulatory Agency
- Recall date
- 2024-12-04
- Status
- Ongoing
- Distribution
- United Kingdom
Official recall notice from UK Medicines and Healthcare products Regulatory Agency
Recall details on Nibble Recalls: https://trynibble.app/recalls/832b0902-ef82-40d7-9350-99e82f007fc7